web3: Bitwise CEO claims Bitcoin is still in its early stages
U.Today
1h ago
Ai Focus
Bitwise CEO commented on BlackRock's views regarding Bitcoin, stating that the adoption of Bitcoin by institutions is still in its early stages.
Helpful
No.Help

外媒:Bitwise 首席执行官 Horsley 回应 BlackRock 的比特币建议时表示,比特币在 2026 年仍处于早期阶段。他认为,机构对比特币的兴趣上升,并不意味着市场已经走到成熟阶段。

机构采用仍在推进

Horsley 认为,BlackRock 的建议更像是一个信号,说明比特币正在被更多大型机构纳入讨论范围。即便到了 2026 年,市场对比特币的配置需求仍在增加。

市场叙事仍偏长期

在他看来,比特币的稀缺性和长期配置属性,仍在推动更多投资者关注这一资产。围绕“是否已经成熟”的争论,也反映出市场对比特币定位仍未完全统一。

Tip
$0
Like
0
Save
0
Views 23
HQYC reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
web3: Toyota's stock price falls due to the recall of Camry hybrid vehicles
Toyota recalls over 508,000 vehicles in the U.S. due to instrument panel defects in Camry hybrids; market attention is on the impact on sales and stock price.
Coinpaper
·2026-08-19 20:41:10
5
web3: Hyperliquid drives the pre-listing sustainable market, HYPE breaks above $58
Hyperliquid suggests that SEC establish rules for the pre-listing perpetual market, and HYPE should rise in sync above $58.
CoinJournal
·2026-08-19 20:41:07
4
web3: Debris from Falcon 9 hits the moon, NASA captures images of a new crater
After the debris from the SpaceX Falcon 9 rocket struck the moon, NASA released new images of the crater and details of its location.
Coinpaper
·2026-08-19 20:41:04
3
web3: PUMP falls 3%, open interest contracts and TVL reach new highs simultaneously
PUMP fell by about 3%, but the open interest, funding rates, and TVL all strengthened, indicating that market leverage and on-chain activity have increased simultaneously.
CoinJournal
·2026-08-19 20:41:01
4
AI is still far from curing cancer, Vivodyne bets on human tissue data
According to Vivodyne, what AI lacks in drug research and development is not computing power, but data that closely resembles the real human response. The company is using an automated human tissue experiment platform to fill this gap.
TechCrunch
·2026-08-19 20:19:35
7
View More